HC Wainwright Estimates Edap Tms FY2029 Earnings

Edap Tms S.A. (NASDAQ:EDAP) – Research analysts at HC Wainwright issued their FY2029 EPS estimates for Edap Tms in a report released on Friday, March 28th. HC Wainwright analyst S. Ramakanth expects that the medical equipment provider will post earnings per share of $0.40 for the year. HC Wainwright has a “Buy” rating and a $19.00 price target on the stock. The consensus estimate for Edap Tms’ current full-year earnings is ($0.60) per share.

Edap Tms (NASDAQ:EDAP) last announced its quarterly earnings data on Thursday, March 27th. The medical equipment provider reported ($0.05) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.11) by $0.06. The business had revenue of $22.69 million for the quarter, compared to analyst estimates of $20.83 million. Edap Tms had a negative net margin of 34.92% and a negative return on equity of 44.21%.

Several other research analysts have also recently issued reports on EDAP. Piper Sandler lowered their price objective on Edap Tms from $5.00 to $4.50 and set an “overweight” rating for the company in a research report on Friday. StockNews.com assumed coverage on Edap Tms in a report on Friday. They issued a “hold” rating for the company.

Edap Tms Stock Performance

NASDAQ:EDAP opened at $1.96 on Monday. The firm has a market capitalization of $72.72 million, a PE ratio of -3.02 and a beta of 0.37. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.18 and a quick ratio of 1.46. The business’s fifty day moving average price is $2.42 and its 200 day moving average price is $2.49. Edap Tms has a 12 month low of $1.96 and a 12 month high of $8.50.

Institutional Investors Weigh In On Edap Tms

Several hedge funds and other institutional investors have recently bought and sold shares of EDAP. Rock Springs Capital Management LP grew its holdings in shares of Edap Tms by 1.5% during the fourth quarter. Rock Springs Capital Management LP now owns 1,591,800 shares of the medical equipment provider’s stock worth $3,518,000 after purchasing an additional 23,800 shares during the last quarter. Schonfeld Strategic Advisors LLC boosted its position in shares of Edap Tms by 48.5% in the 4th quarter. Schonfeld Strategic Advisors LLC now owns 160,800 shares of the medical equipment provider’s stock valued at $355,000 after purchasing an additional 52,500 shares during the period. Parkman Healthcare Partners LLC acquired a new stake in shares of Edap Tms in the 3rd quarter valued at about $395,000. Orion Capital Management LLC grew its stake in Edap Tms by 10.4% during the 3rd quarter. Orion Capital Management LLC now owns 69,800 shares of the medical equipment provider’s stock worth $178,000 after buying an additional 6,600 shares during the last quarter. Finally, Millennium Management LLC increased its position in Edap Tms by 218.5% during the fourth quarter. Millennium Management LLC now owns 48,915 shares of the medical equipment provider’s stock worth $108,000 after buying an additional 33,558 shares during the period. 62.74% of the stock is currently owned by institutional investors and hedge funds.

Edap Tms Company Profile

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.